Kura Oncology Inc (KURA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $713.90M
Last updated: Nov 17, 2026 at 4:33 PM ET
Kura Oncology Inc (KURA) Stock Chart
Kura Oncology (KURA) has a latest price of $7.49 on Nov 17, 2026, 46.1% below its 52-week high of $13.90. Its price fell 33.2% over the past 12 months. The month-end price rose 153.3% over the 10 years through Oct 2026, a compound annual rate of 9.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $36.30 in Nov 2020 and its lowest $4.05 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart KURA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KURA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 40.2%, and over 6 months it fell 16.4%. The month-end price rose 21.4% over the 3 years through Oct 2026, a compound annual rate of 6.7%.
| Period | Change |
|---|---|
| 1 month | -20.0% |
| 3 months | -40.2% |
| 6 months | -16.4% |
| 12 months | -33.2% |
| 12 months, with dividends | -33.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +21.4% | +6.7% |
| 5 years | -37.5% | -9.0% |
| 10 years | +153.3% | +9.7% |
Price by Year
Its best calendar year was 2017, when the price rose 159.3%, and its weakest was 2021, when it fell 57.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $10.26 | -1.3% |
| 2025 | $10.39 | +19.3% |
| 2024 | $8.71 | -39.4% |
| 2023 | $14.38 | +15.9% |
| 2022 | $12.41 | -11.4% |
| 2021 | $14.00 | -57.1% |
| 2020 | $32.66 | +137.5% |
| 2019 | $13.75 | -2.1% |
| 2018 | $14.04 | -8.2% |
| 2017 | $15.30 | +159.3% |
Trading Range
The price is 24.7% below its 50-day average of $9.95 and 23.3% below its 200-day average of $9.77.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $7.49 | |
| 52-week high | $13.90 | -46.1% |
| 52-week low | $6.75 | +11.0% |
| 50-day average | $9.95 | -24.7% |
| 200-day average | $9.77 | -23.3% |
Price Risk
Over 3 years, its largest fall from a peak was 76.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.36 |
| Largest fall, 1 year | -50.0% |
| Largest fall, 3 years | -76.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About KURA
What is KURA's 1-year price change?
Kura Oncology's price fell 33.2% over the past 12 months. With dividends included, the 12-month total return was -33.2%.
What is KURA's 5-year price change?
Kura Oncology's month-end price fell 37.5% over the 5 years through Oct 2026, a compound annual decline of 9.0%. These figures leave out dividends.
What is KURA's 52-week high and low?
Kura Oncology's 52-week high is $13.90 and its 52-week low is $6.75. Its latest price of $7.49 on Nov 17, 2026 is 46.1% below the high.
What is KURA's beta?
Kura Oncology's 1-year beta against the S&P 500 is 1.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 50.0%.
Is the KURA chart free?
Yes. Advanced Charting for KURA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
KURA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors